® Harbert ® Venture Partners II, L.P. | 2 HARBERT MANAGEMENT CORPORATION One of the Leading Asset Management Firms in the Southeast Approximately $3 billion in assets and committed capital, 11 asset classes Legal, Accounting, Compliance and Investor Reporting Functions These operate in conjunction with, but independent of, HVP’s core team of investment professionals, allowing the venture professionals to focus solely on managing the HVP portfolios HMC Also Provides Investment Support – Putting Our Money Where Our Investments Are Strong Investment Infrastructure Harbert Management Corporation Raymond J. Harbert, CEO Michael D. Luce President & COO David A. Boutwell EVP & CAO Business Development/ Investor Relations Risk Management LegalCompliance Charles D. Miller EVP & CFO John W. McCullough SVP & General Counsel Communications Accounting Investor Reporting Internal Audit
® Harbert ® Venture Partners II, L.P. | 3 Harbert Venture Partners Investment Team Partners average 20 years in working with the Southeast venture-backed community Partners average 20 years in working with the Southeast venture-backed community Core team has worked together since 2002, individual working relationships extend back to mid-1990s Core team has worked together since 2002, individual working relationships extend back to mid-1990s TeamRoleTenurePortfolioFocus Will BrookeManaging Partner20+ Aldagen, IBI, Maxcyte, Novamin, Optimal IMX Healthcare Wayne HunterManaging Partner8 Broadsource, Intelliject, Peoplematter, Privaris (observer), Unitrends, Yap Technology Tom RobertsPartner8 Agility, Clarabridge, Controlscan, JackBe, Windchannel Technology, Healthcare IT, Cleantech Bob CrutchfieldVenture Partner2 IBI (observer), Novamin (observer), Optimal (observer) Healthcare Services, IT, Devices John UhrinVenture Partner8 Aldagen (observer), nContact, Intelliject (observer) Devices, Biotech Brian CarneyPrincipal3 Agility (observer), JackBe (observer), Privaris, Windchannel Technology, Healthcare Jenna SporkAnalyst1- Support
® Harbert ® Venture Partners II, L.P. | 4 HVP Investment Strategy: Early Growth Stage Discipline Identify and track promising early stage companies Invest in companies in the adoption phase in an attempt to mitigate risk and the time to achieve positive EBITDA performance Track pre-investment milestones that mitigate technology and market acceptance risk Average period from introduction to initial funding for HVP portfolio is over [12 months] HVP invests in companies when we believe they are ready to scale their product and have a visible path to value creation: IMPORTANT NOTICE: The Fund’s approach to a particular investment may vary depending on the nature of the investment, current market conditions or other factors. Early Growth Stage Focus Profits/Customer Traction Early Stage Growth Stage HVP
® Harbert ® Venture Partners II, L.P. | 5 HVP Investment Focus – Inefficient Markets Major entrepreneurial markets underserved by capital Greater Washington DC Metro IT, Healthcare Research Triangle Park, NC Healthcare, IT Atlanta, GA IT, Devices Orlando/Tampa/Gainesville, FL IT, Healthcare Birmingham, AL Healthcare Services, Healthcare IT Nashville and Memphis, TN Healthcare Services and Healthcare Device Richmond/Charlottesville, VA Healthcare, Healthcare IT Major Entrepreneurial Markets: Secondary Entrepreneurial Markets: Major Entrepreneurial Markets Secondary Entrepreneurial Markets
® Harbert ® Venture Partners II, L.P. | 6 Agility Healthcare Solutions, Inc. Richmond, VA www.agilityhealthcare.com Company Status: Sector: Description: Total Investment: Initial Investment: Exit: Syndicate: HVP II Ownership: HVP II Board Member: Exited HVP I & II portfolio company Healthcare IT Agility provides business process optimization solutions targeted at hospitals and other acute care facilities. The Company combines its proprietary software and implementation services with RFID and other location tracking technologies to provide significant ROI for hospitals in transforming their enterprise patient care management and operational workflow. $800,000 (HVP II), $2,500,000 (HVP I) In August 2008, HVP II structured and led a bridge round of financing to the Company. HVP I led all prior rounds of venture financing. Agility sold to GE Healthcare on September 29, 2008. 1 The Aurora Funds, Eastside Partners, Lunsford Capital N/A Tom Roberts, who played a very active role in managing the exit, resigned from the board upon the closing of the GE acquisition. Agility Healthcare Solutions, Inc. HVP I/II Portfolio 1. Returns for HVP I at exit were 2.44x invested capital (79% IRR) and 1.16x invested capital (over 200% IRR) for HVP II, not including escrow proceeds. IRRs and multiplies are calculated at the investment level and are unaudited and gross of fund level fees and expenses, including the management fee, and incentive allocation, if applicable. IRR is an annualized calculation, and results can be skewed for periods less than a year. IMPORTANT NOTICE: PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.
® Harbert ® Venture Partners II, L.P. | 7 NovaMin Technology, Inc. Alachua, FL www.novamin.com Company Status: Sector: Description: Total Investment: Initial Investment: Current Round: Syndicate: Current HVP II Ownership: HVP II Board Member: Exited HVP II portfolio company Healthcare NovaMin is establishing its proprietary oral health care technology as the next generation active-ingredient foundation for consumer oral health care and professional dental products. NovaMin addresses rapidly growing, unmet oral care needs by amplifying the natural biological defenses and repair mechanisms of the mouth. $2,500,000 In September 2008, HVP II led the Preferred Stock financing for NovaMin. Series D of $5,000,000 Intersouth Partners 17.9% Will Brooke NovaMin Technology, Inc. HVP II Portfolio
® Harbert ® Venture Partners II, L.P. | 8 HVP Investment Strategy - Proprietary Deal Flow Early prospect identification Long term tracking Entrepreneur relationship development Proprietary investment opportunities Community leadership C O -C HAIR 2008 & 2009 C O -C HAIR 2009 C HAIR 2004-2006 I VY F UND S ID M ARTIN I NCUBATOR CHAIR 2010
® Harbert ® Venture Partners II, L.P. | 9 Harbert Venture Partners History ▪ Innovation Developed/Discovered ▪ Commercialization Pathway Determined ▪ Legal, Licensing, IP Covered ▪ Proof of Concept Funding ▪ Seed Stage Funding ▪ Angel Investors ▪ Venture Capital How Can Venture Capital Help SRTTDs? Commercialization Vetting Mentoring/Strategic Guidance Introductions to Entrepreneurs Introductions to Seed Stage/Angel Capital Financial Support & Participation Venture Forums